Literature DB >> 6195031

Protein synthesis in the early stages of cardiac hypertrophy.

K Clarke, L C Ward.   

Abstract

Cardiac hypertrophy, induced in rats by either tri-iodothyronine or isoproterenol, administered daily for 7 days, was monitored using several parameters. Both treatments increased RNA concentrations 24 hr after the first injection, while heart weight increased following 2 injections to 46% above control after 7 days. Cardiac protein synthetic activity, as determined by the rate of peptidyl-puromycin formation, was increased by both tri-iodothyronine and isoproterenol 24 hr after a single injection, implying an increase in the number of functional ribosomes. RNA activity (the rate of peptidyl-puromycin formation per unit RNA) remained constant, suggesting that neither accelerated rates of initiation or translation nor increased activation of pre-existing, non-translating ribosomes was involved in the observed increase in protein synthetic activity. In contrast, constant infusion of [14C] tyrosine indicated no change in protein synthetic rate 24 hr after a single tri-iodothyronine injection and decreased protein synthetic rate after isoproterenol injection. It is concluded that the use of [3H]puromycin to estimate protein synthetic activity may be a more sensitive procedure for detecting early changes in protein synthesis in cardiac hypertrophy than constant isotope infusion, owing to the problems associated with determining the precise precursor pool for protein synthesis in this latter method.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6195031     DOI: 10.1016/0020-711x(83)90217-3

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  9 in total

1.  Adrenergic agents, but not triiodo-L-thyronine induce c-fos and c-myc expression in the rat heart.

Authors:  R D Hannan; A K West
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

Review 2.  Regulation of protein turnover in skeletal and cardiac muscle.

Authors:  P H Sugden; S J Fuller
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

3.  Cardiomyocyte-enriched protein CIP protects against pathophysiological stresses and regulates cardiac homeostasis.

Authors:  Zhan-Peng Huang; Masaharu Kataoka; Jinghai Chen; Gengze Wu; Jian Ding; Mao Nie; Zhiqiang Lin; Jianming Liu; Xiaoyun Hu; Lixin Ma; Bin Zhou; Hiroko Wakimoto; Chunyu Zeng; Jan Kyselovic; Zhong-Liang Deng; Christine E Seidman; J G Seidman; William T Pu; Da-Zhi Wang
Journal:  J Clin Invest       Date:  2015-10-05       Impact factor: 14.808

4.  Expression of the translational repressor NAT1 in experimental models of cardiac hypertrophy.

Authors:  S Jeson Sangaralingham; Brian J Pak; M Yat Tse; Ekaterini Angelis; Michael A Adams; C Smallegange; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2003-03       Impact factor: 3.396

5.  Changes in myosin and creatine kinase mRNA levels with cardiac hypertrophy and hypothyroidism.

Authors:  G T Schuyler; L R Yarbrough
Journal:  Basic Res Cardiol       Date:  1990 Sep-Oct       Impact factor: 17.165

6.  Regression from pathological hypertrophy in mice is sexually dimorphic and stimulus specific.

Authors:  Deanna L Muehleman; Claudia Crocini; Alison R Swearingen; Christopher D Ozeroff; Leslie A Leinwand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-18       Impact factor: 4.733

Review 7.  Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.

Authors:  Oleg E Osadchii
Journal:  Heart Fail Rev       Date:  2007-03-27       Impact factor: 4.654

8.  Systematic evaluation of the adaptability of the non-radioactive SUnSET assay to measure cardiac protein synthesis.

Authors:  Venkatraman Ravi; Aditi Jain; Faiz Ahamed; Nowrin Fathma; Perumal Arumugam Desingu; Nagalingam R Sundaresan
Journal:  Sci Rep       Date:  2018-03-15       Impact factor: 4.379

9.  miR-322-5p targets IGF-1 and is suppressed in the heart of rats with pulmonary hypertension.

Authors:  Martin Connolly; Benjamin E Garfield; Alexi Crosby; Nick W Morrell; Stephen J Wort; Paul R Kemp
Journal:  FEBS Open Bio       Date:  2018-01-24       Impact factor: 2.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.